APA (7th ed.) Citation

PANDA, R., & LANKALAPALLI, S. (2025). Bioavailability Enhancement and Polymorphic Stabilization of One BCS Class IV Metastable Drug Through Novel Formulation Approach. Turkish Journal of Pharmaceutical Sciences, 22(5), 333. https://doi.org/10.4274/tjps.galenos.2025.89956

Chicago Style (17th ed.) Citation

PANDA, Ramakant, and Srinivas LANKALAPALLI. "Bioavailability Enhancement and Polymorphic Stabilization of One BCS Class IV Metastable Drug Through Novel Formulation Approach." Turkish Journal of Pharmaceutical Sciences 22, no. 5 (2025): 333. https://doi.org/10.4274/tjps.galenos.2025.89956.

MLA (9th ed.) Citation

PANDA, Ramakant, and Srinivas LANKALAPALLI. "Bioavailability Enhancement and Polymorphic Stabilization of One BCS Class IV Metastable Drug Through Novel Formulation Approach." Turkish Journal of Pharmaceutical Sciences, vol. 22, no. 5, 2025, p. 333, https://doi.org/10.4274/tjps.galenos.2025.89956.